» Articles » PMID: 11053243

Progesterone Facilitates Chromosome Instability (aneuploidy) in P53 Null Normal Mammary Epithelial Cells

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2000 Oct 29
PMID 11053243
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Mammary epithelial cells from p53 null mice have been shown recently to exhibit an increased risk for tumor development. Hormonal stimulation markedly increased tumor development in p53 null mammary cells. Here we demonstrate that mammary tumors arising in p53 null mammary cells are highly aneuploid, with greater than 70% of the tumor cells containing altered chromosome number and a mean chromosome number of 56. Normal mammary cells of p53 null genotype and aged less than 14 wk do not exhibit aneuploidy in primary cell culture. Significantly, the hormone progesterone, but not estrogen, increases the incidence of aneuploidy in morphologically normal p53 null mammary epithelial cells. Such cells exhibited 40% aneuploidy and a mean chromosome number of 54. The increase in aneuploidy measured in p53 null tumor cells or hormonally stimulated normal p53 null cells was not accompanied by centrosome amplification. These results suggest that normal levels of progesterone can facilitate chromosomal instability in the absence of the tumor suppressor gene, p53. The results support the emerging hypothesis based both on human epidemiological and animal model studies that progesterone markedly enhances mammary tumorigenesis.

Citing Articles

Mechanisms of Drug Resistance and Use of Nanoparticle Delivery to Overcome Resistance in Breast Cancers.

Beyaz H, Uludag H, Kavaz D, Rizaner N Adv Exp Med Biol. 2021; 1347:163-181.

PMID: 34287795 DOI: 10.1007/5584_2021_648.


The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.

Villanueva H, Grimm S, Dhamne S, Rajapakshe K, Visbal A, Davis C J Mammary Gland Biol Neoplasia. 2018; 23(4):237-248.

PMID: 30338425 PMC: 6244884. DOI: 10.1007/s10911-018-9416-0.


Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.

Palaniappan M, Edwards D, Creighton C, Medina D, Conneely O PLoS One. 2018; 13(3):e0194913.

PMID: 29590203 PMC: 5874056. DOI: 10.1371/journal.pone.0194913.


Extranuclear signaling by sex steroid receptors and clinical implications in breast cancer.

Boonyaratanakornkit V, Hamilton N, Marquez-Garban D, Pateetin P, McGowan E, Pietras R Mol Cell Endocrinol. 2017; 466:51-72.

PMID: 29146555 PMC: 5878997. DOI: 10.1016/j.mce.2017.11.010.


Minireview: The Link Between ERα Corepressors and Histone Deacetylases in Tamoxifen Resistance in Breast Cancer.

Legare S, Basik M Mol Endocrinol. 2016; 30(9):965-76.

PMID: 27581354 PMC: 5414611. DOI: 10.1210/me.2016-1072.